Recently, the highly anticipated CPHI China 2026 World Pharmaceutical Raw Materials China Exhibition, which has attracted much attention from the global pharmaceutical industry, came to a successful conclusion in Shanghai. Unilong Industry Co.,Ltd. showcased its core pharmaceutical intermediates, distinctive active pharmaceutical ingredients, and high-value-added fine chemical products with great impact. It engaged in in-depth exchanges with professional buyers from all over the world and comprehensively demonstrated the company’s comprehensive strength in product research and development, quality control, export compliance, and supply chain services. During the exhibition, it achieved fruitful results and received enthusiastic responses.
This year’s CPHI exhibition brings together high-quality resources from the global pharmaceutical industry. It serves as an important platform for enterprises to expand their international markets, connect with overseas clients, and understand industry policies. In the face of increasingly strict international regulatory environments and new policy requirements, our company focused on showcasing the compliance-based export solutions at the exhibition site. These solutions cover aspects such as product ingredient review, qualification document preparation, customs declaration guidance, and full-process risk control, providing stable, safe, and traceable supply chain services for overseas clients. This attracted a large number of buyers to stop by for inquiries and in-depth discussions.
During the exhibition, the popularity of our booth continued to rise. We received new and old customers from dozens of countries and regions such as Europe, Southeast Asia, the Middle East, and Latin America. On the spot, we not only conducted multiple rounds of in-depth business negotiations but also successfully reached intentional orders and long-term cooperation frameworks. Moreover， we established preliminary strategic cooperation relationships with several large overseas pharmaceutical companies and traders， laying a solid foundation for subsequent market expansion.
This participation in CPHI China 2026 not only demonstrated the professional image of Unilong Industry Co., Ltd. in the export of pharmaceutical raw materials and fine chemicals, but also gained valuable customer resources and market information. In the future, Unilong Industry Co., Ltd. will continue to adhere to the principles of compliant operation, quality priority, and the principle of giving priority to customers, continuously deepen its penetration into the international market, continuously enhance product competitiveness and service capabilities, and work together with global partners to contribute to the high-quality development of the pharmaceutical industry.
